PRDM14 and familial pancreatic carcinoma: Similarly, immunohistochemical analyses using tissue microarrays showed that PRDM14 protein was expressed in tumor tissues for breast cancer, 35.9% (n=14 out of 39 cases); lung cancer, 25.6% (10/39); pancreatic cancer, 29.3% (49/167); ovarian cancer, 37.3% (19/51); renal cancer, 38.8% (19/49); prostate cancer, 15.4% (6/39); testicular cancer, 7.0% (6/86); and cervical cancer, 18.4% (9/49).